• Exchange: Soc.Bol SIBE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GRF/P:SM

28.170 EUR 0.530 1.85%

As of 08:03:00 ET on 12/24/2014.

Snapshot for Grifols SA (GRF/P)

Open: 28.360 Day's Range: 27.990 - 28.505 Volume: 4,366
Previous Close: 28.700 52wk Range: 22.605 - 34.600 1-Yr Rtn: +8.55%

Stock Chart for GRF/P

No chart data available.
  • GRF/P:SM 28.170
  • 1D
  • 1M
  • 1Y
28.700
Interactive GRF/P Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRF/P

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.3034
Relative P/E vs. IBEX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 1.6280
Est. PEG Ratio 1.2075
Market Cap (M EUR) 10,766.58
Shares Outstanding (M) 130.71
30 Day Average Volume 112,207
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.89%
Cash Dividend (EUR) 0.1986
Dividend Ex-Date 12/04/2014
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRF/P

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GRF/P

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, Enteral nutrition, diagnostic systems, and medical materials.

Victor Grifols RouraChairman/CEORamon Riera RocaExec VP/Pres:Global Commercial
Alfredo Arroyo GuerraVP/CFOCarlos Roura FernandezVP/Pres:Global Industrial
More Company Profile & Key Executives for GRF/P

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil